Online citations, reference lists, and bibliographies.
← Back to Search

Understanding And Optimizing Use Of Contrast Material For CT Of The Liver.

R. Baron
Published 1994 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Improvements in CT technology have dramatically increased our ability to detect and diagnose liver abnormalities, particularly neoplastic disease. Because of the high prevalence of liver disease in patients referred for abdominal CT examinations, contrast administration and scanning techniques are usually optimized for detection of liver disease on abdominal CT scans. A wide variety of contrast techniques can be used to evaluate the liver, and it is important to understand both the rationale behind each technique and the impact on the quality of the examination when one deviates from these techniques. In addition, the timing of contrast administration and scan acquisition has become critical, and improper timing can cause lesions that are easily visualized to be obscured. This article reviews principles of lesion detection and the effects of various contrast techniques on lesion visualization.
This paper references
10.1148/RADIOLOGY.165.3.3685361
Hepatic metastasis detection: comparison of three CT contrast enhancement methods.
D. Miller (1987)
10.1148/RADIOLOGY.172.1.2662254
Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation.
R. Nelson (1989)
10.1148/RADIOLOGY.154.1.2981114
Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents.
H. Ohishi (1985)
10.1148/RADIOLOGY.165.1.2819941
Metastatic nodules of hepatocellular carcinoma: detection with angiography, CT, and US.
N. Hayashi (1987)
10.1148/RADIOLOGY.178.2.1846240
Benign and malignant nodules in cirrhotic livers: distinction based on blood supply.
O. Matsui (1991)
10.1148/RADIOLOGY.190.3.8115618
Hepatic CT enhancement: comparison of ionic and nonionic contrast agents in the same patients.
T. Chambers (1994)
10.1148/130.3.697
Computed tomographic arteriography of the liver.
A. Prando (1979)
10.1148/RADIOLOGY.171.1.2538862
Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging.
J. Heiken (1989)
10.1148/RADIOLOGY.158.2.3941861
Colorectal carcinoma evaluation with CT: preoperative staging and detection of postoperative recurrence.
P. Freeny (1986)
10.2214/AJR.154.6.2159688
CT of hilar cholangiocarcinoma: late contrast enhancement in six patients.
K. Takayasu (1990)
10.1148/RADIOLOGY.189.3.8234715
Small hepatocellular carcinomas: two-phase dynamic incremental CT in detection and evaluation.
I. Ohashi (1993)
10.1148/RADIOLOGY.159.3.3010374
Hepatic perfusion abnormalities during CT angiography: detection and interpretation.
P. Freeny (1986)
10.2214/AJR.140.2.291
Contrast enhancement of hepatic tumors in CT: comparison between bolus and infusion techniques.
F. Burgener (1983)
Techniques for computed tomography of the liver.
R. Nelson (1991)
10.1148/RADIOLOGY.183.2.1561365
Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography.
P. Soyer (1992)
10.1097/00004728-198705000-00017
Transient hepatic attenuation differences on dynamic computed tomography.
Y. Itai (1987)
10.1148/RADIOLOGY.185.1.1326119
Hepatic parenchymal perfusion defects detected with CTAP: imaging-pathologic correlation.
M. Peterson (1992)
10.1148/RADIOLOGY.175.3.2160675
Detection of hepatocellular carcinoma: comparison of CT during arterial portography with CT after intraarterial injection of iodized oil.
D. Merine (1990)
10.1148/RADIOLOGY.187.2.8475268
Dynamic contrast-enhanced CT of the liver: comparison of contrast medium injection rates and uniphasic and biphasic injection protocols.
J. Heiken (1993)
10.1148/RADIOLOGY.162.1.3024210
Hypervascular hepatic metastases: CT evaluation.
E. Bressler (1987)
10.1148/RADIOLOGY.144.4.6287520
Transient hepatic attenuation difference of lobar or segmental distribution detected by dynamic computed tomography.
Y. Itai (1982)



This paper is referenced by
10.1002/LT.500050113
Management of hepatic metastases.
M. Choti (1999)
10.1111/j.1349-7006.2010.01588.x
Imaging study of pancreatic ductal adenocarcinomas in Syrian hamsters using X‐ray micro‐computed tomography (CT)
Tsukasa Kitahashi (2010)
10.1016/S0899-7071(99)00150-3
Contrast-enhanced hepatic MRI: comparison of half-dose and standard-dose gadolinium DTPA administration in lesion characterization with T1-weighted gradient echo sequences.
D. R. De Corato (1999)
Improved Detectability of Hyper-Dense Nodules with Dual-Energy CT Scans: Phantom Study Using Simulated Liver Harboring Nodules
Enkhjargal Bayasgalan (2019)
10.1007/s11604-009-0399-z
Triple-phase computed tomography during arterial portography with bolus tracking for hepatic tumors
M. Nakai (2009)
10.1007/BF00182460
Focal malignant liver lesions: diagnosis by dynamic incremental CT, early phase
R. M. Marques (2004)
10.2214/AJR.170.1.9423622
Imaging of the liver with helical CT: a survey of scanning techniques.
P. Silverman (1998)
10.1097/00004424-200108000-00008
Hepatocellular Carcinoma: Correlation Between Vascular Endothelial Growth Factor Level and Degree of Enhancement by Multiphase Contrast-Enhanced Computed Tomography
B. K. Kwak (2001)
Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver by means of helical CT: comparison of different contrast medium concentrations within the same patient.
S. Sultana (2003)
10.2214/AJR.08.1818
Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation.
S. H. Yoon (2009)
10.3413/Nukmed-0919-17-08
Influence of scan time point and volume of intravenous contrast administration on blood-pool and liver SUVmax and SUVmean in [18F] FDG PET/CT.
M. Schoen (2018)
10.2214/AJR.167.2.8686630
Hepatocellular carcinoma: iodized-oil CT TNM classification.
C. Valls (1996)
10.1007/978-3-642-72195-3_19
Automatic Bolus Tracking for Spiral CT of the Liver
C. Claussen (1998)
10.2214/AJR.04.1254
Hepatic attenuation differences associated with obstruction of the portal or hepatic veins in patients with hepatic abscess.
K. Lee (2005)
10.1677/ERC-08-0247
Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
S. Scigliano (2009)
10.1148/radiol.10100015
Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations.
J. Kim (2010)
10.1007/s00330-020-07438-9
Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis: diagnostic performance of CT and MRI
J. Min (2020)
10.1007/s003300050888
Opacification of the urinary tract in portal venous spiral CT without delayed scans
H.-P. Dinkel (1999)
10.2214/AJR.173.5.10541087
Cirrhotic liver enhancement on dual-phase helical CT: comparison with noncirrhotic livers in 146 patients.
O. Vignaux (1999)
10.1007/978-3-642-56976-0_12
The Case for Spiral CT
B. Marincek (2000)
10.1016/S0887-2171(02)90028-4
CT in hepatic cirrhosis and chronic hepatitis.
C. Valls (2002)
10.1016/S2171-3669(11)70024-5
Diagnóstico de un hepatocarcinoma tras un hallazgo casual
Helga Rosso González (2011)
10.1016/j.ijrobp.2012.04.041
Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastases.
Christopher C Howells (2012)
Findings in Multidetector Computed Tomography in the diagnosis of hepatocellular carcinoma in patients with cirrhosis and correlation with pathology of liver explants
Diego Haberman (2013)
10.1016/S0899-7071(96)00083-6
Routine pre-contrast CT for liver lesion detection. A re-examination.
N. A. Yassa (1997)
10.1007/978-3-642-56976-0_46
New Contrast Media for Liver CT
A. Spinazzi (2000)
10.1007/s004640000236
Use of CT Hounsfield unit density to identify ablated tumor after laparoscopic radiofrequency ablation of hepatic tumorsrid=""id=""Presented at the annual meeting of the Society of American Gastrointestinal Endoscopic Surgeons (SAGES), Atlanta, Georgia, USA, 29 March–1 April 2000
E. Berber (2000)
10.1016/S1089-3261(03)00071-0
Computed tomography and magnetic resonance imaging of hepatic metastases.
G. Sica (2002)
10.1016/j.ejrad.2012.11.014
Dual-energy CT to detect recurrent HCC after TACE: initial experience of color-coded iodine CT imaging.
Jeongah Lee (2013)
10.1007/s002619900189
Effect of portal venous flow augmentation on liver enhancement with CT
P. García (1997)
10.1007/s10354-013-0179-3
Radiologische Diagnostik primärer Lebermalignome
Benjamin Henninger (2013)
10.5392/JKCA.2015.15.09.411
The Objective Image Analysis for HCC and HH with a Axial Image of Liver CT Scan
In-Gil Hwang (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar